PATOU GARY

Insider CIK 1283535 · PCRX Chief Medical Officer, Director · XENE Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
XENE Xenon Pharmaceuticals Inc.	S Sale	2026-06-05	2026-06-08	1,322	$53.14	$70.3K	24,896	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2026-06-03	2026-06-03	10,507	—	$0	10,507	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2026-06-03	2026-06-03	1,593	—	$0	1,593	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2026-06-01	2026-06-03	2,645	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2026-06-01	2026-06-03	2,645	—	$0	26,218	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2025-06-05	2025-06-06	2,645	—	$0	2,645	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2025-06-05	2025-06-06	17,012	—	$0	17,012	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2024-11-22	2024-11-22	3,086	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2024-11-22	2024-11-22	3,500	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	S Sale	2024-11-22	2024-11-22	2,851	$41.11	$117.2K	23,573	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2024-11-22	2024-11-22	1,046	$39.80	$41.6K	25,613	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2024-11-22	2024-11-22	3,086	$13.48	$41.6K	26,659	SEC↗
XENE Xenon Pharmaceuticals Inc.	S Sale	2024-11-22	2024-11-22	2,040	$41.05	$83.7K	23,573	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2024-11-22	2024-11-22	649	$39.80	$25.8K	26,424	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2024-11-22	2024-11-22	3,500	$7.38	$25.8K	27,073	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2024-06-05	2024-06-05	15,542	—	$0	15,542	SEC↗
XENE Xenon Pharmaceuticals Inc.	S Sale	2023-12-14	2023-12-15	7,598	$41.05	$311.9K	4,902	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2023-12-13	2023-12-15	6,378	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2023-12-13	2023-12-15	2,800	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2023-12-13	2023-12-15	5,144	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	S Sale	2023-12-13	2023-12-15	5,100	$38.94	$198.6K	23,573	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2023-12-13	2023-12-15	6,378	$9.85	$62.8K	29,951	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2023-12-13	2023-12-15	1,278	$39.68	$50.7K	28,673	SEC↗
XENE Xenon Pharmaceuticals Inc.	S Sale	2023-12-13	2023-12-15	7,598	$41.05	$311.9K	4,902	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2023-12-13	2023-12-15	2,880	$9.85	$28.4K	26,453	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2023-12-13	2023-12-15	577	$39.68	$22.9K	25,876	SEC↗
XENE Xenon Pharmaceuticals Inc.	S Sale	2023-12-13	2023-12-15	3,977	$39.84	$158.4K	23,573	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2023-12-13	2023-12-15	1,167	$39.68	$46.3K	27,550	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2023-12-13	2023-12-15	5,144	$9.00	$46.3K	28,717	SEC↗
XENE Xenon Pharmaceuticals Inc.	S Sale	2023-12-13	2023-12-15	2,303	$39.10	$90.0K	23,573	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2023-06-02	2023-06-02	18,475	—	$0	18,475	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2022-11-25	2022-11-28	2,057	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2022-11-25	2022-11-28	2,057	$2.68	$5.5K	25,630	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2022-11-25	2022-11-28	120	$34.37	$4.1K	25,510	SEC↗
XENE Xenon Pharmaceuticals Inc.	S Sale	2022-11-25	2022-11-28	1,937	$34.79	$67.4K	23,573	SEC↗
XENE Xenon Pharmaceuticals Inc.	S Sale	2022-11-23	2022-11-28	2,057	$34.33	$70.6K	23,573	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2022-06-28	2022-06-29	18,000	—	$0	18,000	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2021-12-08	2021-12-10	2,057	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2021-12-08	2021-12-10	2,057	$3.67	$7.5K	25,630	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2021-06-03	2021-06-04	10,000	—	$0	10,000	SEC↗
XENE Xenon Pharmaceuticals Inc.	L Small acq	2021-03-17	2021-06-04	100	$19.49	$1.9K	100	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2020-10-28	2020-10-29	2,057	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2020-10-28	2020-10-29	2,057	$3.76	$7.7K	23,573	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2020-06-01	2020-06-02	10,000	—	$0	10,000	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2019-12-04	2019-12-06	2,057	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2019-12-04	2019-12-06	2,057	$3.56	$7.3K	21,516	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2019-09-16	2019-09-18	15,000	—	$0	15,000	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2018-12-14	2018-12-18	2,057	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2018-12-14	2018-12-18	2,057	$3.07	$6.3K	19,459	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2018-06-14	2018-06-15	8,230	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2018-06-14	2018-06-15	8,230	$3.70	$30.5K	20,258	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2018-06-14	2018-06-15	2,856	$8.30	$23.7K	17,402	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2018-06-04	2018-06-05	15,000	—	$0	15,000	SEC↗
XENE Xenon Pharmaceuticals Inc.	P Buy	2017-08-10	2017-08-14	7,500	$2.78	$20.9K	12,500	SEC↗
XENE Xenon Pharmaceuticals Inc.	P Buy	2017-08-08	2017-08-10	5,000	$3.00	$15.0K	5,000	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2017-06-01	2017-06-02	3,500	—	$0	3,500	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2016-12-06	2016-12-08	12,345	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2016-12-06	2016-12-08	4,403	$7.90	$34.8K	12,028	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2016-12-06	2016-12-08	12,345	$3.21	$39.6K	16,431	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2016-06-02	2016-06-03	3,500	—	$0	3,500	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2015-11-04	2015-11-06	3,497	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2015-11-04	2015-11-06	3,497	$5.22	$18.3K	6,041	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2015-11-04	2015-11-06	1,955	$8.32	$16.3K	4,086	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2015-05-04	2015-05-06	3,086	—	$0	3,086	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2015-01-07	2015-01-09	3,497	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise deriv	2015-01-07	2015-01-21	3,497	—	$0	0	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2015-01-07	2015-01-09	3,497	$4.98	$17.4K	3,497	SEC↗
XENE Xenon Pharmaceuticals Inc.	M Exercise	2015-01-07	2015-01-21	3,497	$4.98	$17.4K	3,497	SEC↗
XENE Xenon Pharmaceuticals Inc.	F Tax w/h	2015-01-07	2015-01-21	953	$22.28	$21.2K	2,544	SEC↗
XENE Xenon Pharmaceuticals Inc.	A Award deriv	2014-11-04	2014-11-06	5,144	—	$0	5,144	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-08-07	2014-08-08	3,524	—	$0	56,476	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-08-07	2014-08-08	1,230	—	$0	1,230	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-08-07	2014-08-08	882	—	$0	4,414	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-08-07	2014-08-08	14,364	—	$0	18,333	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-08-07	2014-08-08	1,230	$1.61	$2.0K	1,230	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-08-07	2014-08-08	882	$5.49	$4.8K	2,112	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-08-07	2014-08-08	14,364	$10.81	$155.3K	16,476	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-08-07	2014-08-08	3,524	$11.68	$41.2K	20,000	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2014-08-07	2014-08-08	20,000	$100.26	$2.01M	0	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-07-14	2014-07-15	7,303	—	$0	32,697	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-07-14	2014-07-15	20,237	—	$0	5,296	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-07-14	2014-07-15	2,460	—	$0	2,460	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-07-14	2014-07-15	20,237	$5.49	$111.1K	22,697	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-07-14	2014-07-15	7,303	$10.81	$78.9K	30,000	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2014-07-14	2014-07-15	27,593	$86.91	$2.40M	2,407	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-07-14	2014-07-15	2,460	$1.61	$4.0K	2,460	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2014-07-14	2014-07-15	2,107	$87.58	$184.5K	0	SEC↗
PCRX Pacira Pharmaceuticals, In	A Award deriv	2014-06-03	2014-06-05	25,000	—	$0	25,000	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-05-12	2014-05-13	10,000	—	$0	25,532	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2014-05-12	2014-05-13	10,000	$75.00	$750.0K	0	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-05-12	2014-05-13	10,000	$5.49	$54.9K	10,000	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-05-09	2014-05-13	13,164	—	$0	4,920	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2014-05-09	2014-05-13	6,836	—	$0	35,532	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2014-05-09	2014-05-13	20,000	$74.08	$1.48M	0	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-05-09	2014-05-13	6,836	$5.49	$37.5K	20,000	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2014-05-09	2014-05-13	13,164	$1.61	$21.2K	13,164	SEC↗
PCRX Pacira Pharmaceuticals, In	J Other	2014-03-11	2014-03-12	504	—	$0	702	SEC↗
PCRX Pacira Pharmaceuticals, In	J Other	2013-11-18	2013-11-19	83	—	$0	198	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2013-10-01	2013-10-04	20,000	—	$0	18,084	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2013-10-01	2013-10-04	20,000	$1.61	$32.2K	20,000	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2013-10-01	2013-10-04	20,000	$48.92	$978.4K	0	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2013-07-02	2013-07-02	10,000	—	$0	38,084	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2013-07-02	2013-07-02	10,000	$30.00	$300.0K	0	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2013-07-02	2013-07-02	10,000	$1.61	$16.1K	10,000	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2013-07-01	2013-07-02	19,042	—	$0	0	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2013-07-01	2013-07-02	10,958	—	$0	48,084	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2013-07-01	2013-07-02	30,000	$1.61	$48.3K	30,000	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2013-07-01	2013-07-02	30,000	$29.25	$877.5K	0	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2013-04-12	2013-04-16	10,000	—	$0	19,042	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2013-04-12	2013-04-16	10,000	$1.61	$16.1K	10,000	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2013-04-12	2013-04-16	10,000	$30.00	$300.0K	0	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise deriv	2013-04-01	2013-04-03	30,000	—	$0	29,042	SEC↗
PCRX Pacira Pharmaceuticals, In	M Exercise	2013-04-01	2013-04-03	30,000	$1.61	$48.3K	30,000	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2013-04-01	2013-04-03	11,300	$28.82	$325.7K	0	SEC↗
PCRX Pacira Pharmaceuticals, In	S Sale	2013-04-01	2013-04-03	18,700	$27.75	$518.9K	11,300	SEC↗
PCRX Pacira Pharmaceuticals, In	A Award deriv	2012-06-07	2012-06-11	60,000	—	$0	60,000	SEC↗
PCRX Pacira Pharmaceuticals, In	A Award deriv	2012-06-05	2012-06-07	40,000	—	$0	40,000	SEC↗
PCRX Pacira Pharmaceuticals, In	A Award deriv	2012-06-05	2012-06-11	40,000	—	$0	40,000	SEC↗